Ready to join a team committed to moving cutting-edge gene therapies into the clinical setting for patients and families devastated by rare neurological genetic diseases? 


Based in the Chicagoland area, AveXis is a clinical-stage gene therapy company with an initial candidate, AVXS-101, in the pivotal phase of study for the treatment of spinal muscular atrophy (SMA)Type 1 and in a Phase 1 clinical trial for the treatment of SMA Type 2.  In addition, we intend to expand the study of gene therapy into two other rare neurological monogenic disorders: Rett syndrome (RTT) and a genetic form of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene.


To view our latest job openings and apply, please see below.

Job Listings

You can view all open positions or use the following search form to find jobs that suit your specific career interests.

The system cannot access your location for 1 of 2 reasons:
  1. Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
  2. Your location information has yet to be received. Please wait a moment then hit [Search] again.